Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
open-label, multiple dose, single-group, 12 week trial in HIV-infected patients with
hyperlipidemia while using lopinavir/ritonavir; both male or female subjects.